IBDEI208 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34008,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,34008,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,34009,0)
 ;;=C88.0^^131^1680^195
 ;;^UTILITY(U,$J,358.3,34009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34009,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,34009,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,34009,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,34010,0)
 ;;=C91.02^^131^1680^3
 ;;^UTILITY(U,$J,358.3,34010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34010,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34010,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,34010,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,34011,0)
 ;;=C92.02^^131^1680^6
 ;;^UTILITY(U,$J,358.3,34011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34011,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34011,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,34011,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,34012,0)
 ;;=D09.3^^131^1680^45
 ;;^UTILITY(U,$J,358.3,34012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34012,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,34012,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,34012,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,34013,0)
 ;;=C22.0^^131^1680^86
 ;;^UTILITY(U,$J,358.3,34013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34013,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,34013,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,34013,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,34014,0)
 ;;=C24.9^^131^1680^110
 ;;^UTILITY(U,$J,358.3,34014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34014,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,34014,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,34014,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,34015,0)
 ;;=C50.922^^131^1680^134
 ;;^UTILITY(U,$J,358.3,34015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34015,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,34015,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,34015,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,34016,0)
 ;;=C34.91^^131^1680^152
 ;;^UTILITY(U,$J,358.3,34016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34016,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,34016,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,34016,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,34017,0)
 ;;=C50.921^^131^1680^156
 ;;^UTILITY(U,$J,358.3,34017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34017,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,34017,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,34017,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,34018,0)
 ;;=C90.02^^131^1680^167
 ;;^UTILITY(U,$J,358.3,34018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34018,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,34018,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,34018,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,34019,0)
 ;;=D51.9^^131^1680^25
 ;;^UTILITY(U,$J,358.3,34019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34019,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,34019,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,34019,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,34020,0)
 ;;=C79.51^^131^1680^30
 ;;^UTILITY(U,$J,358.3,34020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34020,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,34020,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,34020,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,34021,0)
 ;;=C80.1^^131^1680^163
 ;;^UTILITY(U,$J,358.3,34021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34021,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
